Semax certificate of analysis explained: what to check and why

Last updated 2026-07-24

What is a certificate of analysis for Semax?

A certificate of analysis (CoA) is a lab report that documents what's actually in a vial. It reports the peptide's identity, purity, sterility, and contaminants. A real CoA names the lab, batch or lot number, test methods, and pass/fail criteria. It's the only third-party evidence you have that the vial contains what the label claims. Semax is a seven-amino-acid synthetic peptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a fragment of adrenocorticotropic hormone. It has no FDA approval in the United States ^[1]. The compound appears on the nominated list for compounding bulks but is not on the final 503A or 503B bulk drug substance lists, meaning U.S. compounding pharmacies cannot legally use it in patient-specific formulations without an approved NDA ^{[2] [3]}. Most Semax sold online originates from overseas research chemical suppliers or gray-market peptide vendors operating without regulatory oversight. Because Semax is not approved, there's no manufacturing standard to audit against. A CoA is your only window into production quality. If the CoA is missing, vague, or copied from another batch, you have no idea whether you're dosing the peptide, a related impurity, or something else entirely.

What tests should a Semax certificate of analysis include?

A complete CoA runs five core tests: identity confirmation, purity quantification, sterility, endotoxin content, and microbial limits. Each one answers a different risk question. Identity confirmation uses mass spectrometry (MS), typically electrospray ionization or MALDI-TOF. The test measures molecular weight and compares it to the known weight of Semax (813.9 Da). A match confirms the sequence is correct. Some labs report only the expected mass without showing the actual spectrum, which tells you nothing about what's in the vial. Purity is measured by high-performance liquid chromatography (HPLC), usually reverse-phase. The report should state purity as a percentage (commonly 95 to 99% for research-grade peptides) and show a chromatogram with the Semax peak isolated from impurities. Acetylated Semax and truncated fragments are common contaminants that HPLC can detect ^[4]. Sterility testing follows USP <71> or equivalent. The sample is incubated in microbial growth media for 14 days. No growth means pass. This test matters if you're using the peptide as a nasal spray or injection, since contamination can cause infection. Endotoxin testing measures bacterial lipopolysaccharides using the Limulus amebocyte lysate (LAL) assay. The passing threshold is typically <1 EU/mg for injectable products. High endotoxin loads trigger immune activation, even in sterile solutions. Microbial limits (USP <61>) quantify aerobic bacteria, yeast, and mold. Passing thresholds are <100 CFU/g for total aerobic count and <10 CFU/g for yeast and mold in non-sterile products. If the peptide is sold as sterile, this test should report zero. A CoA that omits any of these tests is incomplete. If it omits identity or purity, it's worthless.

How do you read purity and impurity data on a CoA?

The purity line tells you what fraction of the powder is the target peptide. A result of 98.2% means 98.2% Semax, 1.8% other stuff. The "other stuff" can be truncated peptide sequences, starting materials, acetylation byproducts, or degradation products. HPLC separates these by retention time, and the chromatogram should show one dominant peak (Semax) and small or absent secondary peaks. Some CoAs report "purity by mass" and "purity by area." Area purity is calculated from the chromatogram's peak areas and tends to run higher. Mass purity accounts for water, salts, and counter-ions. If a vendor quotes 99% purity without specifying which method, assume they're using the more flattering number. Impurity identity matters more than you'd think. N-acetyl-Semax, a common synthetic byproduct, has neurotrophic activity on its own and a longer half-life ^[5]. If your vial is 5% N-acetyl-Semax, you're dosing a different molecule at an unknown ratio. A good CoA names the major impurities or at least quantifies the largest secondary peaks. Semax research often uses material synthesized in Russian labs or sourced from Chinese peptide manufacturers. One 2016 study on copper coordination explicitly tested N-terminal acetylation and found it altered metal binding and aggregation behavior ^[6]. If the CoA doesn't resolve acetylated forms, you can't know whether the biology in the cited studies matches what's in your vial. Semax Labs publishes per-batch CoAs from its fulfillment pharmacy partner, showing HPLC chromatograms and mass spectra for each production run.

What does microbial and endotoxin testing tell you?

Peptides are grown in bacterial cultures or synthesized chemically, then purified. Neither process is inherently sterile. Even if the final filtration step removes live bacteria, endotoxins (fragments of dead bacterial cell walls) can remain. Endotoxins are heat-stable and can't be autoclaved away. The LAL assay detects endotoxin at concentrations as low as 0.005 EU/mL. For a nasal spray dosed at 600 mcg per spray, a passing threshold is typically <0.5 EU per dose. If the CoA reports 5 EU/mg, that's 3 EU per 600 mcg dose, 6x over the limit. Symptoms of endotoxin exposure include fever, fatigue, and flu-like malaise. It's not dramatic, but it's unpleasant and entirely preventable. Microbial limits matter less for nasal sprays than for injections, since the nasal mucosa tolerates low bacterial counts. But if a vial fails sterility testing (growth in the 14-day culture), that's a hard stop. You're spraying live bacteria into a mucous membrane. Gray-market peptide sellers rarely publish endotoxin data. The test costs $150 to 300 per batch, and many skip it. If the CoA says "pending" or "not tested," the vendor chose not to spend the money.

Why do some Semax certificates of analysis look identical across batches?

Batch-averaged CoAs are common in the peptide resale market. A supplier tests one reference batch, then issues the same CoA for every subsequent lot sold under that product code. This is cheaper than per-batch testing and works fine if the supplier's upstream manufacturing is consistent. It's also how you end up dosing a failed batch that nobody caught. Lot numbers matter. A real CoA includes a unique batch or lot identifier that matches the vial label. If the CoA says "Batch: Semax-2023" and your vial says "Lot 040624," they don't correspond. Some vendors print a batch number on a template CoA and never update it. Others list the test date as the CoA's "expiry," implying the document itself expires, which is incoherent. A CoA doesn't expire, the product does. The test lab's name and contact information should appear on the CoA, often with an accreditation logo (ISO 17025 is the standard for analytical labs). If the lab isn't named, you can't verify it exists. If it's named but has no web presence or published scope, it might be a garage operation or a fabrication. One tell: if the purity is exactly 98.0% across multiple batches, that's suspicious. Real HPLC results vary batch-to-batch, typically in a range like 96.8 to 99.1%. A supplier reporting 98.0% every time is likely quoting a nominal spec, not test data.

What's the difference between a CoA and a third-party lab test?

A CoA is issued by the manufacturer or the lab they hired. It's self-reported. A third-party test is commissioned by someone other than the seller, usually a buyer, reviewer, or regulatory body. The latter is far more trustworthy because the economic incentive is inverted. Some peptide communities run group buys and fund independent testing through labs like Janoshik Analytical or Chromate. These tests cost $200 to 500 per sample and typically include HPLC purity, mass spec identity, and sometimes FTIR (infrared spectroscopy) to detect gross substitutions. Results are posted publicly. If a vendor's CoA says 99% and the third-party test says 87%, the CoA was either outdated, faked, or batch-averaged from a better lot. U.S. compounding pharmacies that follow USP <795> (non-sterile compounding) or <797> (sterile compounding) standards are required to test each batch if the preparation is high-risk or the source ingredient isn't USP-grade. Since Semax has no USP monograph, any compounded Semax would require full analytical testing per batch. This is one reason licensed compounding pharmacies rarely handle it: the testing cost per batch often exceeds the revenue from patient-specific prescriptions. If you're sourcing Semax from a research supplier, ask for the raw data files (the.mzML or.raw file from mass spec, the.chromatogram from HPLC). A legitimate lab can provide these. A reseller with a template CoA cannot.

How does Semax peptide stability affect CoA interpretation?

Semax degrades over time, especially in solution and at room temperature. Degradation products include truncated peptides (missing one or more amino acids) and oxidized forms (methionine oxidation at position 1 is common). These show up as secondary peaks on HPLC. A fresh batch might test at 99% purity, but the same batch six months later could test at 93% if stored improperly. A CoA's test date matters. If the CoA is dated January 2023 and you're buying in July 2024, that's 18 months of potential degradation. Lyophilized (freeze-dried) peptides are more stable than reconstituted solutions, but even powders degrade in humid or warm conditions. The CoA should state storage conditions and expiry or retest date. One 2022 study on Semax and copper-induced aggregation found that the peptide's stability in solution depends on pH and metal ion concentration ^[7]. At physiological pH, Semax has a half-life of weeks to months in phosphate buffer. In saline with preservatives (common in nasal sprays), stability is better but still limited. If a vendor sells pre-mixed nasal spray and claims a 12-month shelf life, ask for stability data. A CoA from the powder batch doesn't prove the reconstituted product is stable. Some sellers provide a Certificate of Conformance instead of a CoA. A CoC states that a batch meets the product spec, but it doesn't show test data. It's a one-line assurance, not evidence. Peptides sold with CoCs instead of CoAs are red flags unless the vendor is a large-scale API (active pharmaceutical ingredient) manufacturer with audited quality systems.

What does Semax research say about quality and reproducibility?

Most Semax efficacy data comes from Russian clinical and preclinical studies dating back to the 1990s. The peptide was developed at the Institute of Molecular Genetics in Moscow and has been used in Russian neurology practice for ischemic stroke, cognitive impairment, and optic nerve damage. These studies consistently report neuroprotective effects, but the material used was produced by Russian pharmaceutical manufacturers under domestic regulatory standards, not FDA or EMA oversight ^[8]. A 2020 transcriptomic study in rats demonstrated that Semax modulates neurotrophin gene expression after cerebral ischemia ^[9]. A 2021 proteomics paper confirmed dose-dependent neuroprotection in the same model ^[10]. Both used Semax sourced from the original Russian developer. The question Western researchers ask is: does gray-market Semax have the same sequence, purity, and activity? Nobody has published a head-to-head comparison, so we don't know. Semax's mechanism involves brain-derived neurotrophic factor (BDNF) upregulation, modulation of the μ opioid receptor, and effects on dopaminergic and serotonergic signaling ^{[11] [12]}. Small sequence errors or impurities could alter receptor binding. A 2025 study on spinal cord injury in mice explicitly tested a supplier-provided Semax sample and confirmed activity at the Oprm1 gene ^[12], but the study didn't disclose the supplier or publish a CoA. This is typical: research papers cite Semax by sequence, not by verified source. If you're dosing for cognitive enhancement or neuroprotection and the CoA shows 90% purity with 10% unknown impurities, you're not replicating the Russian clinical experience. You're running an n=1 experiment with undefined material.

What are the most common CoA red flags for Semax?

First, no CoA at all. If a vendor won't provide one, walk away. Second, a CoA with no batch number that matches your vial. Third, a CoA that lists only expected values ("purity: 98% (spec)") without actual test results. These are product specs, not certificates of analysis. Fourth, missing mass spectrometry. HPLC alone can't confirm peptide identity because retention time can be faked by a different molecule of similar size and polarity. MS is non-negotiable. Fifth, a CoA with test dates older than 12 months for a lyophilized powder or 6 months for a reconstituted solution. Sixth, a CoA from an unnamed lab or a lab that isn't ISO 17025 accredited. Seventh, identical purity numbers across multiple batches, suggesting batch averaging or template reuse. Eighth, endotoxin listed as "not detected" without stating the detection limit. A real LAL assay reports something like "<0.05 EU/mL," not a binary pass/fail. Ninth, sterility reported as "pass" without naming the test method (USP <71>, Ph. Eur. 2.6.1, or equivalent). Tenth, chromatograms or spectra that are low-resolution images, not raw data plots. A blurry HPLC chromatogram can hide secondary peaks. If you see two or more of these, assume the CoA is marketing material, not a lab report. Check where to buy Semax from a reputable source for vendors who publish per-batch testing.

How does compounding pharmacy testing differ from research supplier testing?

U.S. compounding pharmacies that follow USP <795> or <797> are required to verify the identity and purity of any non-USP ingredient used in patient formulations. Since Semax is not USP-grade and is not on the FDA's 503A or 503B approved lists ^{[2] [3]}, a licensed pharmacy cannot legally compound it for human use under current regulations unless it obtains an approved NDA, which no entity has done for Semax. If a pharmacy were to compound Semax (hypothetically, in a jurisdiction where it's legal), it would need to source the peptide from a registered supplier, test each batch for identity (MS), purity (HPLC), sterility, endotoxin, and microbial limits, and retain those records for inspection. The pharmacy would also need to demonstrate beyond-use dating based on stability studies or published data. Most compounding pharmacies don't have in-house MS or HPLC, so they send samples to contract labs, adding $300 to 800 per batch to the cost. Research suppliers and gray-market vendors operate outside this framework. They're selling "not for human consumption" peptides, so they aren't held to pharmaceutical manufacturing standards. A CoA from a research supplier might be accurate, but there's no regulatory audit confirming the lab is competent or the data is real. Some suppliers publish CoAs from reputable third-party labs (like Janoshik or Colmaric Analyticals), which adds credibility. Others use in-house testing or overseas labs with no English-language web presence.

What should you do if a Semax CoA looks incomplete or suspicious?

First, contact the vendor and ask for the missing data: raw chromatograms, mass spectra, the lab's ISO 17025 certificate, and confirmation that the batch number matches your vial. If they provide it, great. If they deflect or ignore the request, assume the CoA is fake or batch-averaged. Second, consider commissioning a third-party test. Janoshik Analytical, Chromate, and several other peptide testing labs offer HPLC and MS testing for $200 to 400 per sample. You ship a small amount of your peptide, they run the tests, and they email you the results. This is the gold standard for verification. Online nootropics and peptide communities sometimes organize group buys to split the testing cost. Third, cross-reference the CoA with the scientific literature. If the CoA says the peptide is 99% pure but multiple studies report using Semax at 95 to 98% purity ^[13], the claimed purity might be inflated. If the CoA shows significant impurities but doesn't identify them, search for papers on Semax synthesis and purification to see what the expected byproducts are. Acetylated forms and truncated sequences are common ^{[4] [6]}. Fourth, evaluate the vendor's track record. Has anyone posted independent test results for their Semax? Are they transparent about their supply chain? Do they respond to questions with detail or marketing fluff? If you can't find any third-party confirmation, treat the CoA as unverified. Fifth, weigh the risk. If you're dosing Semax for research purposes at low doses (300 to 600 mcg per day) and the CoA looks weak, the worst-case scenario is you're dosing a less pure or inactive peptide. If you're using higher doses or planning a longer protocol, the risk of dosing unknown impurities or degradation products goes up. At that point, confirming the CoA with third-party testing makes sense. More on typical dosing is covered in how many mg of Semax a day.

Frequently asked questions

Can you trust a Semax certificate of analysis from an overseas supplier?

Possibly, if the CoA lists a named, accredited lab and includes a batch number matching your vial. Many reputable Chinese peptide manufacturers publish legitimate third-party CoAs. The risk is batch averaging (the CoA describes a reference batch, not yours) or template reuse. Ask for raw data files (chromatograms, mass spectra) to verify authenticity. If the vendor won't provide them, assume the CoA is marketing material.

What purity percentage should Semax be?

Research-grade Semax is typically 95 to 99% pure by HPLC. The clinical literature often reports using material at 96 to 98%. Higher purity is better, but anything above 95% is workable if the impurities are identified and non-toxic. Below 90% suggests poor synthesis or degradation and increases the risk of dosing unknown byproducts or truncated peptides.

Does Semax need sterility testing if it's a nasal spray?

Yes. Sterility testing confirms the absence of viable bacteria and fungi. Even though the nasal mucosa tolerates some microbial load, a contaminated product can cause sinus infection, immune activation, or systemic illness if high bacterial counts are present. A passing sterility test (USP <71>) is standard for any peptide intended for nasal or injectable use.

What does a mass spectrometry result on a Semax CoA prove?

Mass spec confirms the peptide's molecular weight matches the expected value for Semax (813.9 Da). A match proves the seven-amino-acid sequence is correct. It doesn't quantify purity (HPLC does that), but it's the only way to verify identity. Without MS, you're trusting the label and HPLC retention time, which can be faked by a different molecule of similar size.

What is a good endotoxin level for Semax?

For nasal or injectable use, <0.5 EU per dose is standard. For a 600 mcg dose, that's <1 EU/mg of peptide. The LAL assay can detect endotoxin at 0.005 EU/mL or lower. If the CoA reports 5 EU/mg, that's 10x over the safe threshold and likely to cause fever or malaise. Endotoxin is heat-stable and can't be removed once present.

Why don't all Semax vendors publish certificates of analysis?

Testing costs $300 to 800 per batch for a full CoA (HPLC, MS, sterility, endotoxin, microbial limits). Gray-market vendors selling at low margins often skip it to cut costs. Some publish partial CoAs (HPLC only, no MS) or batch-averaged CoAs from a single reference lot. If a vendor doesn't publish a CoA, they're either reselling someone else's product without testing or don't want you to see the results.

Can a certificate of analysis be faked or altered?

Yes. A PDF CoA is trivial to forge. The only way to verify it is to contact the lab directly using contact information you find independently (not the info on the CoA) and ask them to confirm the batch number and results. Some communities publish known fake CoAs as warnings. If a vendor's CoA looks too clean or has identical results across multiple batches, assume it's template-based or fabricated.

What's the difference between HPLC purity and peptide content?

HPLC purity measures the fraction of the target peptide relative to other peptides or organic impurities. Peptide content accounts for water, salts, and counter-ions (like acetate or TFA) that add mass but aren't the peptide. A sample might be 98% pure by HPLC but only 85% peptide by mass if it contains 15% water and salts. Vendors sometimes quote HPLC purity because it's higher.

How long is a Semax certificate of analysis valid?

A CoA describes the state of a batch at the time of testing. If the peptide is stored properly (lyophilized powder at 4°C or lower), the CoA remains accurate for 12 to 24 months. If stored improperly or reconstituted, degradation begins immediately. Always check the CoA's test date and your vial's storage conditions. A CoA older than 18 months is likely outdated unless the peptide is still frozen.

Should Semax CoAs include heavy metal testing?

Not routinely, unless the synthesis involves metal catalysts or the peptide binds metals (Semax does coordinate copper and zinc in some conditions ^[6][7]). Heavy metals aren't a common contaminant in synthetic peptides, but if you're sourcing from an unknown manufacturer, ICP-MS testing for lead, arsenic, cadmium, and mercury adds confidence. This isn't standard for research peptides and would need to be requested separately.

What does 'not for human consumption' mean on a peptide certificate of analysis?

It's a liability disclaimer used by research chemical suppliers to avoid regulation as a drug manufacturer. The phrase means the product isn't manufactured under GMP (good manufacturing practice) and hasn't passed FDA or EMA approval. It doesn't mean the peptide is unsafe, just that it's sold for research purposes only. Many people dose these peptides anyway, accepting the risk that the CoA might be incomplete or inaccurate.

Can you compare Semax CoAs across different vendors to find the best source?

Yes, but only if the CoAs are real and from the same test methods. Compare purity, impurity profiles, endotoxin levels, and sterility results. If one vendor reports 99% purity and another reports 96%, check whether they're using the same HPLC method and whether the 99% result is from a single batch or batch-averaged. The best approach is to pick a vendor with a track record of third-party testing posted by independent buyers.

What's the difference between Semax and N-acetyl-Semax on a CoA?

N-acetyl-Semax is a synthetic byproduct or intentional modification with an acetyl group on the N-terminus. It has different pharmacokinetics (longer half-life) and possibly different receptor activity. Some CoAs list it as an impurity, others sell it as a separate product. If your Semax CoA shows a secondary peak at a different retention time and doesn't identify it, it could be the acetylated form. More detail is covered in Semax vs N-acetyl-Semax amidate.

Sources

1. FDA Drugs@FDA database: Semax has no FDA approval in the United States
2. 21 CFR 216.23, final 503A bulks list: Semax is not on the FDA's 503A approved bulk drug substances list for compounding
3. 21 CFR 216.24, 503B bulks list: Semax is not on the FDA's 503B approved bulk drug substances list for outsourcing facilities
4. PMID 16362768, Neurochemical Research 2005: Semax activates dopaminergic and serotoninergic systems; acetylated forms are common synthetic byproducts
5. PMID 27921334, Journal of Molecular Recognition 2017: N-acetyl-Semax has neurotrophic activity and a longer half-life than unmodified Semax
6. PMID 27586814, Journal of Inorganic Biochemistry 2016: N-terminal acetylation of Semax alters copper(II) and zinc(II) coordination and biological properties
7. PMID 35080861, ACS Chemical Neuroscience 2022: Semax affects copper-induced Abeta aggregation and amyloid formation; stability depends on pH and metal ion concentration
8. PMID 29798983, Zhurnal Nevrologii i Psikhiatrii 2018: Semax has been used in Russian neurology practice for ischemic stroke and cognitive impairment
9. PMID 32580520, Genes 2020: Semax modulates neurotrophin gene expression after cerebral ischemia in rats at the transcriptome level
10. PMID 34201112, International Journal of Molecular Sciences 2021: Brain protein expression profile confirms dose-dependent neuroprotection by Semax in a rat ischemia-reperfusion model
11. PMID 16635254, Journal of Neurochemistry 2006: Semax binds specifically and increases brain-derived neurotrophic factor (BDNF) protein levels in rat basal forebrain
12. PMID 40692165, British Journal of Pharmacology 2025: Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury
13. PMID 19633950, Cellular and Molecular Neurobiology 2010: Semax and Pro-Gly-Pro activate transcription of neurotrophins and their receptor genes after cerebral ischemia